Complete Genomics, Inc. (GNOM) Posts Q3 Loss of $0.65, Offers Q4 Volume Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| COMPLETE GENOM (NASDAQ: GNOM) | Delayed: 67.78 +1.95 (2.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.83 | 52 Week High | $3.50 | |||
| Open | $66.43 | 52 Week Low | $1.57 | |||
| Day High | $68.87 | P/E | N/A | |||
| Day Low | $66.35 | EPS | $-2.35 | |||
| Volume | 10,108 | |||||
